abstract |
The present invention relates to the field of biotechnology, in particular antibodies or antigen-binding fragments thereof and uses thereof. More specifically, the present invention relates to antibodies that specifically bind CD47 and PD-L1. In addition, the present invention relates to nucleic acids encoding the above-described antibodies or antigen-binding fragments thereof, expression vectors, methods for preparing antibodies, and the use of the above-described antibodies and compositions in the treatment of cancer. |